TFRC and cancer: The work N19 in Table 1 and Table 2 [72] proposes a novel approach for intracellular delivery of cytC: encapsulation in ferritin capsules, which bind to the CD71 (TfR1) cellular receptors (highly expressed by cancer cells) and are then absorbed via receptor-mediated endocytosis.